发明名称 Inhibitor of τ protein phosphorylation
摘要 8-[2-(2-pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid has a protein tyrosine phosphatase 1B (PTP1B) inhibitory action, an Akt activating action, a GSK-3β phosphorylation promoting action, and a suppressive action on τ protein phosphorylation induced by Aβ1-42, and is useful as a therapeutic drug for Alzheimer-type dementia, an antidepressant and/or an anti-aging drug.
申请公布号 US9603821(B2) 申请公布日期 2017.03.28
申请号 US201414769707 申请日期 2014.02.21
申请人 Nishizaki Bioinformation Research Institute 发明人 Nishizaki Tomoyuki;Tanaka Akito
分类号 A61K31/20 主分类号 A61K31/20
代理机构 Leydig, Voit & Mayer, Ltd. 代理人 Leydig, Voit & Mayer, Ltd.
主权项 1. A method of activating Akt comprising administering an effective amount of DCP-LA to a patient in need thereof, wherein the DCP-LA activates PKCε, and the PKCε directly activates Akt in the patient.
地址 Kobe JP
您可能感兴趣的专利